
Jonathan G. Stine, MD MSc, FACP
@JonathanStineMD
Followers
3K
Following
13K
Media
974
Statuses
6K
Global Clinical Program Lead – Late CVRM @AstraZeneca | #MASH researcher | #run #lift #snowboard #read #garden | Views my own
Gaithersburg, MD
Joined July 2019
After 8 yrs in academic medicine, I'm absolutely delighted to announce I’ve joined @AstraZeneca as a Global Clinical Lead. Starting today, I hope to advance innovative therapies for liver & metabolic diseases alongside an incredible team. Onward to this new chapter! #MASLD #MASH.
14
5
157
Congrats to all who received @AASLDtweets #TLM2025 abstract acceptances yesterday! Looking forward to catching up on all that is new in Hepatolgoy this November in DC!.
1
1
21
RT @penn_state: What if you could reverse liver disease? By 2030, one in two adults is expected to have chronic liver disease. Penn State's….
psu.edu
Penn State research explores how therapeutic exercise helps improve liver health and manage fatty liver disease.
0
2
0
Celebrated 8 incredible years of Stine Lab with a team lunch today! Grateful for the hard work, discoveries, and camaraderie that made our journey so impactful. Here’s to the science, the memories, and the friendships that last far beyond the lab. #MASLD #Research @PennStHershey
3
1
32
Thanks again for your interest in our work! Appreciate the chance to speak with the @GastroHep team about #exercise and #MASLD.
“Exercise in Patients With Metabolic Dysfunction-Associated Steatohepatitis” with Jonathan G. Stine, MD, MSc @JonathanStineMD @PennStHershey #MASH.
0
1
7
New national survey of hepatology & GI providers: Despite 96% believing weight loss meds help #MASLD, 77% rarely/never prescribe them due to low comfort & limited training. Hunge thanks to @geneyim @MeenaBBansal for leading this effort 👉
journals.lww.com
(MASLD), FDA-approved medications for weight loss remain underutilized. Results: We conducted a survey before resmetirom approval of hepatology and gastroenterology providers practicing in 44 states....
1
6
30
RT @ChannapragadaV: Honored to receive the Hepatology Resident of the Year award last night. Deeply grateful to @PennStIMchiefs and @PennSt….
0
2
0
RT @JVLazarus: @shivaramsingh @PrajnaAnirvan @JonathanStineMD @EASLnews @AASLDtweets @APASLnews So important to have real-world evidence on….
journals.lww.com
d steatotic liver disease/NAFLD management guidelines published between January 1, 2013, and June 31, 2024, through databases including PubMed/MEDLINE, Cochrane, and CINAHL. In total, 35 qualifying...
0
2
0
RT @shivaramsingh: 👆Happy to share this latest publication from our group. This publication is very dear to me. Grateful to all my coauthor….
0
15
0
RT @ChannapragadaV: MASH day was incredible! I learned so much today from Dr. Stine, Dr. Alkhouri, and Dr. Rotman - truly inspiring! @Jonat….
0
2
0
RT @NASH_and_coffee: Coffee, science, clinical care. The perfect triad!. #MASLD #MASH #Liver . #MASHDay2025
0
1
0
Just a couple of #liver docs spending a Thursday together discussing all things #MASLD #MASH here @PennStHershey #MASHDay2025 @NASH_and_coffee @AlkhouriNaim @ChannapragadaV
0
2
30
Session #1 on epidemiology and clinical perspectives in #MASLD is in the books for @PennStHershey #MASHDay. Incredible talks and discussion from the audience and panelists! @KofiClarkeMD @ChannapragadaV @NASH_and_coffee @AlkhouriNaim
0
4
11
Full house from the moderator’s table here @PennStHershey #MASH Day 2025! @GlobalLiver #MASHDay2025 @KofiClarkeMD
0
3
11
Can’t wait to have @NASH_and_coffee @AlkhouriNaim join us tomorrow as invited speakers for @PennStHershey #MASH Day 2025! . Looking forward to your talks and journal club!!.
0
3
11
🌍 June 12 is Global Fatty Liver Day! A call to action against the silent epidemic of #MASLD and #MASH. Know your risk. Get screened. Take action. Liver health is essential. #FattyLiverDay #LiverHealth #EndMASLD #GlobalHealth #MASHAwareness2025
0
3
14
Thursday, June 12, join @PennStateHealth for #MASHDay 2025! Kicking off at 7:30 a.m. EST with a continental breakfast & Product Theatre. Live online & in‑person from the University Conference Center in Hershey. Don't miss the latest in #MASLD research!.
ce.med.psu.edu
Penn State Health Metabolic Dysfunction-Associated Steatohepatitis (MASH) Day is a continuing education program of Penn State College of Medicine taking place in Hershey, Pa.
0
1
6